C
Chris Sander
Researcher at Harvard University
Publications - 730
Citations - 273726
Chris Sander is an academic researcher from Harvard University. The author has contributed to research in topics: Large Hadron Collider & Protein structure. The author has an hindex of 178, co-authored 713 publications receiving 233287 citations. Previous affiliations of Chris Sander include Purdue University & University of Leeds.
Papers
More filters
Journal ArticleDOI
miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1.
Jinhong Chang,Emmanuelle Nicolas,Debora S. Marks,Chris Sander,Anthony Lerro,Marie Annick Buendia,Chunxiao Xu,William S. Mason,Thomas Moloshok,Roque Bort,Kenneth S. Zaret,John M. Taylor +11 more
TL;DR: These studies show that miR-122, a 22-nucleotide microRNA, is derived from a liver-specific non-coding polyadenylated RNA transcribed from the gene hcr, which may be a specific mRNA target, CAT-1, which is expressed in all mammaliantissues but with lower levels in adult liver.
Journal ArticleDOI
Enlarged representative set of protein structures
Uwe Hobohm,Chris Sander +1 more
TL;DR: To reduce redundancy in the Protein Data Bank of 3D protein structures, which is caused by many homologous proteins in the data bank, a representative set of structures is selected to reduce time and effort in statistical analyses.
Journal ArticleDOI
The Immunoglobulin Fold: Structural Classification, Sequence Patterns and Common Core
TL;DR: A systematic comparison of 23 Ig domain structures with less than 25% pairwise residue identity was performed using automatic structural alignment and analysis of beta-sheet and loop topology, revealing a common structural core of only four beta-strands and four different topological subtypes that correlate with the length of the intervening sequence between strands c and e, the most variable region in sequence.
Journal ArticleDOI
Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers
Iñigo Landa,Tihana Ibrahimpasic,Laura Boucai,Rileen Sinha,Jeffrey A. Knauf,Ronak Shah,Snjezana Dogan,Julio C. Ricarte-Filho,Gnana P. Krishnamoorthy,Bin Xu,Nikolaus Schultz,Michael F. Berger,Chris Sander,Barry S. Taylor,Ronald Ghossein,Ian Ganly,James A. Fagin +16 more
TL;DR: These data support a model of tumorigenesis whereby PDTCs and ATCs arise from well-differentiated tumors through the accumulation of key additional genetic abnormalities, many of which have prognostic and possible therapeutic relevance.
Journal ArticleDOI
Protein normal-mode dynamics: trypsin inhibitor, crambin, ribonuclease and lysozyme.
TL;DR: A new method for modelling protein dynamics using normal-mode analysis in internal co-ordinates, particularly well suited for modelling collective motion, makes possible direct visualization of biologically interesting modes, and is complementary to the more time-consuming simulation of molecular dynamics trajectories.